All Type of News
KFDA Drug Safety Director nominated to Choi Soo-yung.
The KFDA appointed Mr. Choi Soo-yung, former head of Kyungin regional KFDA office, to the top position of Drug Safety Bureau, a core position at the KFDA, on Feb. 18 succeeding to Mr. Choi Yun-pan who was abruptly ar...
R&D investment found 4% level of net sales.
Domestic drug makers revealed their hot enthusiasm in developing new drugs amid expectation of the first birth of domestic new drug this year. Despite a difficult management environment under the IMF economic crisis t...
GMP for pharmaceutical bulk materials to implement from 2001.
The GMP for pharmaceutical raw materials seems to be implemented from year 2001, and for the biological products including vaccines from year 2002, the KFDA announced.
So far the the KFDA recommended the GMP for ph...
Mr. Choi Soo-yung nominated to head of Drug Safety Administration Bureau of KFDA.
(Flash report.)
Mr. Choi Soo-yung, the former head of the Kyungin KFDA office (government grade II-A official) was appointed to the director of the Drug Safety Administration Bureau of KFDA as of Feb. 18.
Mr. Ch...
Shareholder's meeting of most listed drug firms scheduled on Mar. 12.
23 listed pharmaceutical companies (fiscal year ended at Dec. 31) excluding the firms in process of court arbitration made schedules for their shareholder's meeting on March 12 and 19. 18 companies including Dong-A on...
Separation system during this extraordinary session.
National Assembly may decide schedules for Medical/pharmacy separation system during this extraordinary session.
The 201th extraordinary session of the National Assembly was scheduled to open for a 20 day term ...
50 billion Won sales targeted in 1999 by GlaxoWellcome Korea.
GlaxoWellcome Korea (President: Kim Jin-ho) established the company management objective this year aiming at a base construction of business profit ensuing the previous year by intensifying the sales organization and ...
Patent dispute on Interferon anticancer drug ended.
A 8 year patent dispute on Interferon between Cheil Jedang and Roche, a Swiss multinational pharmaceutical corporation, has been ended recently.
The 2nd division of the Supreme Court (Chief Chancellor: Cho Moo-jae)...
KPA responsible for direction and control of RP(Retail price labelling) system.
On Feb. 10 the MOHW endorsed "Administration guidelines of drug retail price labelling system" submitted by the KPA. The guidelines described key points of drug price investigation in details conducted by the KPA, and...
Mr. Choi Soo-yung likely nominated to director of Drug Safety dept. of KFDA.
The KFDA seems to find out a way to turn their deteriorated moral into normal atmosphere again since Director of Drug Safety department Kim Yon-pan was arrested on Feb. 10 in charge of bribery received from 12 drug an...
